Navigation Links
Regeneron Announces March 2012 Investor Conference Presentations
Date:2/28/2012

TARRYTOWN, N.Y., Feb. 28, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Cowen and Company 32nd Annual Healthcare Conference at 10:40 a.m. Eastern Time on Tuesday, March 6, 2012
  • Barclays Capital 2012 Global Healthcare Conference at 3:45 p.m. Eastern Time on Wednesday, March 14, 2012
  • The sessions may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page.  Archived versions of the presentations will be available for thirty days after the live webcasts. 

    Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets two products in the United States, one for the treatment of neovascular (wet) age-related macular degeneration and another for the treatment of a rare inflammatory condition.  Additionally, Regeneron has three regulatory applications pending before the U.S. Food and Drug Administration (FDA) and 10 drug candidates in clinical development.  More information and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information:  

     Manisha Narasimhan, Ph.D.Peter DworkinInvestor RelationsCorporate Communications914-847-512914.847.764manisha.narasimhan@regeneron.com

    peter.dworkin@regeneron.com


    '/>"/>
    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related biology technology :

    1. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals
    2. Regeneron Pharmaceuticals and BioMed Realty Trust Host Ribbon-Cutting Ceremony at the Landmark at Eastview
    3. Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
    4. Regeneron Announces Presentation at the 2010 Deutsche Bank BioFest
    5. Regeneron Announces Presentation at the 29th Annual J.P. Morgan Healthcare Conference
    6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
    7. Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary
    8. Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016
    9. Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
    10. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
    11. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2017)... ... May 24, 2017 , ... Patient Monitoring and ... Wi-Fi connectivity to reduce the amount of wiring in a healthcare facility and ... mobile devices including infusion pumps, heart and hypertension monitoring, glucose monitoring, and other ...
    (Date:5/23/2017)... Colorado (PRWEB) , ... May 23, 2017 , ... A ... as the most troublesome and difficult to control weed in 12 categories of broadleaf ... , Almost 200 weed scientists across the U.S. and Canada participated in the 2016 ...
    (Date:5/23/2017)... ... May 22, 2017 , ... NetDimensions has been ranked as ... Globe™ for Corporate Learning, 2017. , Aragon Research defines Leaders as organizations who ... perform against those strategies. NetDimensions’ ranking as a Leader due to its strengths ...
    (Date:5/23/2017)... ... May 23, 2017 , ... Energetiq Technology, a world ... facility expansion to accommodate its rapid growth. , The renovations at the company’s ... of the existing areas. The expansion includes, a state-of-the-art engineering facility, and a ...
    Breaking Biology Technology:
    (Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
    (Date:3/22/2017)... NEW YORK , March 21, 2017 /PRNewswire/ ... Customer Marketing Cloud used by retailers such as ... in its platform — Product Recommendations and Replenishment. Using ... to give more personalized product and replenishment recommendations ... purchases, but also on predictions of customer intent ...
    (Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
    Breaking Biology News(10 mins):